Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1969 1
1975 1
1976 1
1979 3
1980 3
1985 1
2005 1
2006 1
2007 3
2008 13
2009 6
2010 10
2011 8
2012 8
2013 17
2014 13
2015 14
2016 17
2017 26
2018 22
2019 27
2020 42
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

203 results
Results by year
Filters applied: . Clear all
Page 1
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.
Jabbar-Lopez ZK, Yiu ZZN, Ward V, Exton LS, Mohd Mustapa MF, Samarasekera E, Burden AD, Murphy R, Owen CM, Parslew R, Venning V, Warren RB, Smith CH. Jabbar-Lopez ZK, et al. Among authors: warren rb. J Invest Dermatol. 2017 Aug;137(8):1646-1654. doi: 10.1016/j.jid.2017.04.009. Epub 2017 Apr 27. J Invest Dermatol. 2017. PMID: 28457908 Free PMC article. Review.
Safety of selective IL-23p19 inhibitors for the treatment of psoriasis.
Crowley JJ, Warren RB, Cather JC. Crowley JJ, et al. Among authors: warren rb. J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1676-1684. doi: 10.1111/jdv.15653. Epub 2019 Jun 27. J Eur Acad Dermatol Venereol. 2019. PMID: 31054215 Free PMC article. Review.
Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.
Sawyer LM, Malottki K, Sabry-Grant C, Yasmeen N, Wright E, Sohrt A, Borg E, Warren RB. Sawyer LM, et al. Among authors: warren rb. PLoS One. 2019 Aug 14;14(8):e0220868. doi: 10.1371/journal.pone.0220868. eCollection 2019. PLoS One. 2019. PMID: 31412060 Free PMC article.
The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.
Egeberg A, Gisondi P, Carrascosa JM, Warren RB, Mrowietz U. Egeberg A, et al. Among authors: warren rb. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1695-1706. doi: 10.1111/jdv.16273. Epub 2020 Mar 15. J Eur Acad Dermatol Venereol. 2020. PMID: 32022950 Free PMC article. Review.
Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F. Twelves S, et al. Among authors: warren rb. J Allergy Clin Immunol. 2019 Mar;143(3):1021-1026. doi: 10.1016/j.jaci.2018.06.038. Epub 2018 Jul 21. J Allergy Clin Immunol. 2019. PMID: 30036598 Free PMC article.
Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease.
Reich K, Warren RB, Coates LC, Di Comite G. Reich K, et al. Among authors: warren rb. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1161-1173. doi: 10.1111/jdv.16124. Epub 2020 Jan 7. J Eur Acad Dermatol Venereol. 2020. PMID: 31785165 Review.
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.
Smith CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, Burden AD, Coates LC, Cruickshank M, Hadoke T, MacMahon E, Murphy R, Nelson-Piercy C, Owen CM, Parslew R, Peleva E, Pottinger E, Samarasekera EJ, Stoddart J, Strudwicke C, Venning VA, Warren RB, Exton LS, Mohd Mustapa MF. Smith CH, et al. Among authors: warren rb. Br J Dermatol. 2017 Sep;177(3):628-636. doi: 10.1111/bjd.15665. Br J Dermatol. 2017. PMID: 28513835 No abstract available.
Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus.
Mrowietz U, Barker J, Boehncke WH, Iversen L, Kirby B, Naldi L, Reich K, Tanew A, van de Kerkhof PCM, Warren RB. Mrowietz U, et al. Among authors: warren rb. J Eur Acad Dermatol Venereol. 2018 Oct;32 Suppl 3:3-14. doi: 10.1111/jdv.15218. Epub 2018 Sep 20. J Eur Acad Dermatol Venereol. 2018. PMID: 30238510
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial.
Warren RB, Blauvelt A, Poulin Y, Beeck S, Kelly M, Wu T, Geng Z, Paul C. Warren RB, et al. Br J Dermatol. 2021 Jan;184(1):50-59. doi: 10.1111/bjd.19341. Epub 2020 Sep 6. Br J Dermatol. 2021. PMID: 32594522
Ixekizumab for the treatment of psoriasis: up-to-date.
Craig S, Warren RB. Craig S, et al. Among authors: warren rb. Expert Opin Biol Ther. 2020 Jun;20(6):549-557. doi: 10.1080/14712598.2020.1729736. Epub 2020 Mar 10. Expert Opin Biol Ther. 2020. PMID: 32050819 Review.
203 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback